These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 24574517)
1. Androgen receptor promotes the oncogenic function of overexpressed Jagged1 in prostate cancer by enhancing cyclin B1 expression via Akt phosphorylation. Yu Y; Zhang Y; Guan W; Huang T; Kang J; Sheng X; Qi J Mol Cancer Res; 2014 Jun; 12(6):830-42. PubMed ID: 24574517 [TBL] [Abstract][Full Text] [Related]
2. Stroma-induced Jagged1 expression drives PC3 prostate cancer cell migration; disparate effects of RIP-generated proteolytic fragments on cell behaviour and Notch signaling. Delury C; Hart C; Brown M; Clarke N; Parkin E Biochem Biophys Res Commun; 2016 Mar; 472(1):255-61. PubMed ID: 26921446 [TBL] [Abstract][Full Text] [Related]
3. JAGGED1 expression is associated with prostate cancer metastasis and recurrence. Santagata S; Demichelis F; Riva A; Varambally S; Hofer MD; Kutok JL; Kim R; Tang J; Montie JE; Chinnaiyan AM; Rubin MA; Aster JC Cancer Res; 2004 Oct; 64(19):6854-7. PubMed ID: 15466172 [TBL] [Abstract][Full Text] [Related]
4. Correlation of Sprouty1 and Jagged1 with aggressive prostate cancer cells with different sensitivities to androgen deprivation. Terada N; Shiraishi T; Zeng Y; Aw-Yong KM; Mooney SM; Liu Z; Takahashi S; Luo J; Lupold SE; Kulkarni P; Getzenberg RH J Cell Biochem; 2014 Sep; 115(9):1505-15. PubMed ID: 24604720 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways. Wang Z; Li Y; Banerjee S; Kong D; Ahmad A; Nogueira V; Hay N; Sarkar FH J Cell Biochem; 2010 Mar; 109(4):726-36. PubMed ID: 20052673 [TBL] [Abstract][Full Text] [Related]
6. Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions. Pedrosa AR; Trindade A; Carvalho C; Graça J; Carvalho S; Peleteiro MC; Adams RH; Duarte A Oncotarget; 2015 Sep; 6(27):24404-23. PubMed ID: 26213336 [TBL] [Abstract][Full Text] [Related]
7. Emodin inhibits the proliferation of PC3 prostate cancer cells in vitro via the Notch signaling pathway. Deng G; Ju X; Meng Q; Yu ZJ; Ma LB Mol Med Rep; 2015 Sep; 12(3):4427-4433. PubMed ID: 26081222 [TBL] [Abstract][Full Text] [Related]
8. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer. Dulinska-Litewka J; McCubrey JA; Laidler P Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951 [TBL] [Abstract][Full Text] [Related]
9. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells. Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705 [TBL] [Abstract][Full Text] [Related]
10. Combination DLL4 with Jagged1-siRNA can enhance inhibition of the proliferation and invasiveness activity of human gastric carcinoma by Notch1/VEGF pathway. Sun HW; Wu C; Tan HY; Wang QS Hepatogastroenterology; 2012 May; 59(115):924-9. PubMed ID: 22020917 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of androgen receptors by NaAsO Kim Y; Park SE; Moon JW; Kim BM; Kim HG; Jeong IG; Yoo S; Ahn JB; You D; Pak JH; Kim S; Hwang JJ; Kim CS Prostate; 2017 Jul; 77(10):1128-1136. PubMed ID: 28556958 [TBL] [Abstract][Full Text] [Related]
12. MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT. Shen T; Wang W; Zhou W; Coleman I; Cai Q; Dong B; Ittmann MM; Creighton CJ; Bian Y; Meng Y; Rowley DR; Nelson PS; Moore DD; Yang F J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33586682 [TBL] [Abstract][Full Text] [Related]
13. The androgen receptor-lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells. Mirzakhani K; Kallenbach J; Rasa SMM; Ribaudo F; Ungelenk M; Ehsani M; Gong W; Gassler N; Leeder M; Grimm MO; Neri F; Baniahmad A Oncogene; 2022 Feb; 41(7):943-959. PubMed ID: 34667276 [TBL] [Abstract][Full Text] [Related]
14. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells. Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370 [TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor variant III renders glioma cancer cells less differentiated by JAGGED1. Kim EJ; Kim SO; Jin X; Ham SW; Kim J; Park JB; Lee JY; Kim SC; Kim H Tumour Biol; 2015 Apr; 36(4):2921-8. PubMed ID: 25514871 [TBL] [Abstract][Full Text] [Related]
16. Complex impacts of PI3K/AKT inhibitors to androgen receptor gene expression in prostate cancer cells. Liu L; Dong X PLoS One; 2014; 9(10):e108780. PubMed ID: 25360799 [TBL] [Abstract][Full Text] [Related]
17. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins. Xu Y; Chen SY; Ross KN; Balk SP Cancer Res; 2006 Aug; 66(15):7783-92. PubMed ID: 16885382 [TBL] [Abstract][Full Text] [Related]
18. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines. Wang Y; Romigh T; He X; Orloff MS; Silverman RH; Heston WD; Eng C Hum Mol Genet; 2010 Nov; 19(22):4319-29. PubMed ID: 20729295 [TBL] [Abstract][Full Text] [Related]
19. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines. Paliouras M; Diamandis EP Biol Chem; 2008 Jun; 389(6):773-80. PubMed ID: 18627304 [TBL] [Abstract][Full Text] [Related]
20. Antiproliferative effects of γ-secretase inhibitor, a Notch signalling inhibitor, in multiple myeloma cells and its molecular mechanism of action. Hu J; Zhu X; Lu Q J Int Med Res; 2013 Aug; 41(4):1017-26. PubMed ID: 23839278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]